| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.072 | 0.2 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.24 | 0.2 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.076 | 0.2 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |